BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25320957)

  • 1. Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients.
    Robert MC; Arafat SN; Ciolino JB
    Eye Contact Lens; 2014 Nov; 40(6):376-81. PubMed ID: 25320957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in Boston keratoprosthesis type 1.
    Kanellopoulos AJ; Asimellis G
    Cornea; 2014 Sep; 33(9):914-8. PubMed ID: 25014143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of corneal melting after Boston Keratoprosthesis.
    Robert MC; Dohlman CH
    Semin Ophthalmol; 2014; 29(5-6):349-57. PubMed ID: 25325860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Situ Corneal Cross-Linking for Recurrent Corneal Melting After Boston Type 1 Keratoprosthesis.
    Tóth G; Bucher F; Siebelmann S; Bachmann B; Hermann M; Szentmáry N; Nagy ZZ; Cursiefen C
    Cornea; 2016 Jun; 35(6):884-7. PubMed ID: 27032020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of the acellular porcine cornea crosslinked with UVA/riboflavin as scaffolds for Boston Keratoprosthesis.
    Li Q; Zhao H; Wang H; Zhao G
    Biomater Adv; 2022 Jun; 137():212822. PubMed ID: 35929237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Risk Factors, and Surgical Management of Boston Type 1 Keratoprothesis Corneal Melts, Leaks, and Extrusions.
    Chan CC; LoVerde L; Qiang J; Nordlund ML; Holland EJ
    Cornea; 2016 Aug; 35(8):1049-56. PubMed ID: 27391092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient corneal thinning in eyes undergoing corneal cross-linking.
    Holopainen JM; Krootila K
    Am J Ophthalmol; 2011 Oct; 152(4):533-6. PubMed ID: 21726844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal Melt after Boston Keratoprosthesis: Clinical Presentation, Management, Outcomes and Risk Factor Analysis.
    Bouhout S; Robert MC; Deli S; Harissi-Dagher M
    Ocul Immunol Inflamm; 2018; 26(5):693-699. PubMed ID: 28080168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update.
    Robert MC; Črnej A; Shen LQ; Papaliodis GN; Dana R; Foster CS; Chodosh J; Dohlman CH
    Ocul Immunol Inflamm; 2017 Jun; 25(3):413-417. PubMed ID: 27015032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomechanical properties of corneal tissue after ultraviolet-A-riboflavin crosslinking.
    Beshtawi IM; O'Donnell C; Radhakrishnan H
    J Cataract Refract Surg; 2013 Mar; 39(3):451-62. PubMed ID: 23506922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, Randomized, Multicenter, Double-Masked, Clinical Trial of Corneal Cross-Linking for Boston Keratoprosthesis Carrier Tissue.
    De Arrigunaga S; Akpek EK; Aldave AJ; Mian SI; Zurakowski D; Ciolino JB;
    Am J Ophthalmol; 2023 May; 249():39-48. PubMed ID: 36581190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-operative optical coherence tomography in corneal lamellar graft reinforcement for Boston type I keratoprosthesis corneal melt.
    Zeng L; Chen M; Lin L; Zhai J; Chen J; Gu J
    Indian J Ophthalmol; 2023 Jul; 71(7):2892-2896. PubMed ID: 37417141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal crosslinking (CXL) with 18-mW/cm
    Fischinger I; Seiler TG; Santhirasegaram K; Pettenkofer M; Lohmann CP; Zapp D
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1521-1525. PubMed ID: 29666915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of corneal cross-linking on ocular response analyzer waveform-derived variables in keratoconus and postrefractive surgery ectasia.
    Hallahan KM; Rocha K; Roy AS; Randleman JB; Stulting RD; Dupps WJ
    Eye Contact Lens; 2014 Nov; 40(6):339-44. PubMed ID: 25365551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal collagen cross-linking: a review of 1-year outcomes.
    Chang CY; Hersh PS
    Eye Contact Lens; 2014 Nov; 40(6):345-52. PubMed ID: 25343263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Refractory Keratitis After a Boston Type I Keratoprosthesis With Corneal Collagen Cross-Linking.
    Zarei-Ghanavati S; Irandoost F
    Cornea; 2015 Sep; 34(9):1161-3. PubMed ID: 26114820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal collagen cross-linking for nonectatic disorders: a systematic review.
    Bettis DI; Hsu M; Moshirfar M
    J Refract Surg; 2012 Nov; 28(11):798-807. PubMed ID: 23347375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and functional correlations in riboflavin UV A corneal collagen cross-linking for keratoconus.
    Mazzotta C; Caporossi T; Denaro R; Bovone C; Sparano C; Paradiso A; Baiocchi S; Caporossi A
    Acta Ophthalmol; 2012 May; 90(3):259-65. PubMed ID: 20456255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Successful Corneal Crosslinking in a Patient with Corneal Ectasia Associated with Stevens-Johnson Syndrome.
    Li Y; Lu LM; Gokul A; Ziaei M
    Optom Vis Sci; 2021 Jan; 98(1):13-17. PubMed ID: 33394926
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.